Table 2.
Adverse drug events among the study subjects
Adverse drug events | Test vaccine (n = 533) |
Reference vaccine (n = 267) |
P value |
---|---|---|---|
Number of subjects with ADEs | 53 (9.94%) | 46 (17.23%) | 0.0032 |
Local ADEs* | |||
Pain | 59 (7.69%) | 59 (13.56%) | 0.0075 |
Redness | 16 (2.81%) | 12 (3.37%) | 0.065 |
Swelling | 4 (0.75%) | 6 (1.87%) | 0.1559 |
Systemic ADEs* | |||
Fever | 2 (0.38%) | 4 (1.5%) | 0.1931 |
Headache | 2 (0.38%) | 2 (0.75%) | 0.8607 |
Ear pain | 1 (0.19%) | 0 (0%) | 0.0826 |
Urticaria | 1 (0.19%) | 0 (0%) | 0.0826 |
Joint pain | 0 (0%) | 1 (0.19%) | 0.0826 |
Nausea | 0 (0%) | 1 (0.19%) | 0.0826 |
*Multiple response.